Medindia LOGIN REGISTER
Medindia
Advertisement

Essilor Cancels Four Million Shares

Tuesday, July 13, 2010 Corporate News
Advertisement
CHARENTON-LE-PONT, France, July 13, 2010 OnJune 28, 2010, Essilor cancelled 4,000,000 shares, in line with itscommitment not to create any dilution for existing shareholders. The two-parttransaction was carried out as follows:
Advertisement

The world leader in ophthalmic optical products, Essilor Internationalresearches, develops, manufactures and markets around the world a wide rangeof lenses to improve and protect eyesight. Its flagship brands areVarilux(R), Crizal(R), Essilor(R), Definity(R) and Xperio(TM).
Advertisement

Based in France, the company reported consolidated revenue of more thanEUR3.2 billion in 2009, with 34,700 employees and operations in 100 countries.

For more information, please visit http://www.essilor.com.

The Essilor share trades on the NYSE Euronext Paris market and isincluded in the CAC 40 index.- 2,130,000 shares were cancelled to offset the dilutive impact of the vesting of performance shares or the exercise of stock options granted to employees. - 1,870,000 shares were cancelled to offset the dilution resulting from the conversion of the now mature OCEANE convertible bonds. The shares had been purchased as part of a program launched in 2008 to buy back up to 6,900,000 shares for allocation on conversion of the OCEANE bonds then outstanding. To date, Essilor has bought back 5,200,000 shares under this program, of which 3,370,000 have now been cancelled.

SOURCE Essilor
Sponsored Post and Backlink Submission


Latest Press Release on Corporate News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close